Pyrazolo[1,5-d][1,2,4]triazine-5(4H)-acetamides as inhibitors of the NLRP3 inflammasome pathway

The invention relates to novel compounds for use as inhibitors of NLRP3 inflammasone production, wherein such compounds are as defined by compounds of formula (I) and wherein the integers R

Saved in:
Bibliographic Details
Main Authors VAN OPDENBOSCH, Nina, LLAVERIA CROS, Josep, VAN ROMPAEY, Dries, OEHLRICH, Daniel, VAN GOOL, Michiel Luc Maria, LAMKANFI, Mohamed, MARTINEZ VITURRO, Carlos Manuel
Format Patent
LanguageEnglish
Published 15.12.2022
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:The invention relates to novel compounds for use as inhibitors of NLRP3 inflammasone production, wherein such compounds are as defined by compounds of formula (I) and wherein the integers R
Bibliography:Application Number: AU20210257619